SHAHID ALI: Open Payments
NPI 1376573733 · CHURCHVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 33 payments from 11 companies in 2025. Trend: 2023 $1,607 · 2024 $2,090 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $236 |
| Lundbeck LLC | 3 | $68 |
| Alkermes, Inc. | 2 | $51 |
| Gilead Sciences, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Indivior Inc. | 1 | $20 |
Products named: VRAYLAR, REXULTI, ARISTADA, CAPLYTA, FANAPT, COBENFY, INVEGA SUSTENNA, JOURNAVX.
Industry payments across NY — which companies pay providers there.
